CION Cancer Clinics

Plasma cell leukaemia: understanding the outlook | CION Cancer Clinics

Plasma cell leukaemia is an aggressive relative of multiple myeloma, and its outlook is generally more serious. It has improved with newer myeloma medicines and stem cell transplant, and it varies widely. What matters most is how deeply the disease responds to the first treatment, along with fitness, kidney function and gene changes. This page explains those factors and the usual treatment path, without survival figures. At CION Cancer Clinics, every leukaemia, MDS and MPN case is reviewed by our haematologist and discussed at a tumour board before a plan is agreed.

Call 1800 202 8726

Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027

17+specialists on panel

15,000+patients treated

35+centres across Telangana & AP

4.8★ / 800+Google rating

On this page

What is the outlook with plasma cell leukaemia?
Does it matter whether it is primary or secondary?
Which factors change your own outlook?
How is plasma cell leukaemia usually treated?
What do families often get wrong about the outlook?
What can this page not tell you?
Common questions about plasma cell leukaemia

The short answer

What is the outlook with plasma cell leukaemia?

Plasma cell leukaemia is one of the more aggressive blood cancers, and the outlook is generally more serious than for ordinary multiple myeloma. It has improved with newer myeloma medicines and transplant, and it varies a great deal from one person to another.

What the illness is

Plasma cells are white cells in the bone marrow that make antibodies. In multiple myeloma, abnormal plasma cells build up inside the marrow. In plasma cell leukaemia, large numbers of these abnormal cells also circulate in the blood. That usually means the disease is growing fast and spreading beyond the marrow.

Why this page gives no survival figures

Prognosis means the likely course of an illness. Published figures for plasma cell leukaemia come from small groups of patients, many treated before today's medicines were available. They describe groups, not you. A number from the internet can frighten a family without telling them anything reliable about their own person.

What does shape the outlook

Your haematologist looks at whether this is the first appearance of the disease or a change from existing myeloma, how fit you are, how well your kidneys work, the gene changes in the cancer cells, and above all how deeply the disease responds to the first treatment.

Two kinds

Does it matter whether it is primary or secondary?

Primary plasma cell leukaemia Secondary plasma cell leukaemia

Appears as a new diagnosis, with no earlier myeloma Develops in someone already treated for multiple myeloma

The patient has usually not had earlier treatment, so more options remain The disease has already outgrown earlier treatments

Treatment is planned to be intensive from the start where possible Choices depend on which medicines were used before

Outlook is serious, but response to modern treatment can be good Outlook is usually more serious, and comfort and quality of life weigh heavily

Not sure whether this applies to you?

Ask an oncologist

What the team weighs

Which factors change your own outlook?

No single factor decides it. Your haematologist reads them together, and some change as treatment goes on.

Response to first treatment

The single most important factor. A deep response, where very few abnormal cells can be found, is linked to a better course.

This is only known after treatment starts.

Fitness and age

Fitness decides whether intensive treatment and a stem cell transplant are possible. Age matters less than overall health. Heart and lung problems, diabetes and how active the person was before falling ill are all part of that judgement.

Kidney function

Plasma cell leukaemia often damages the kidneys. How quickly they recover affects which medicines can be given.

Gene changes in the cells

A test called FISH looks for chromosome changes. Some are called high risk, and they are common in this illness.

On the report as

del(17p), t(4;14), t(14;16)
1q gain

Blood counts and calcium

Very low counts, a high calcium level and a high LDH, a marker of fast-growing cells, point to more active disease.

The usual path

How is plasma cell leukaemia usually treated?

Urgent first steps

Protecting the kidneys, bringing down a high calcium, treating infections and giving transfusions if needed. These often happen in the first days, before or alongside cancer treatment.
Induction treatment

A combination of myeloma medicines, such as bortezomib, lenalidomide, daratumumab and a steroid, to bring the disease under control quickly. The exact mix depends on your kidneys and fitness.
Stem cell transplant, if suitable

Fitter patients who respond well are usually offered high-dose treatment with their own stem cells, arranged at a transplant centre. A donor transplant is occasionally considered for selected patients.
Maintenance

Ongoing treatment, often tablets or injections, to keep the disease controlled for as long as possible after the transplant or induction.
Regular review

Blood tests, urine tests and sometimes marrow tests track the response. If the disease returns, other combinations or clinical trials may be options.

Leave a number, we will call you

One field. No form to fill in, and no charge for the call.

Commonly believed

What do families often get wrong about the outlook?

"The internet gave us a number, so we know how long there is."

Those figures come from small, older studies and describe groups, not individuals. Many patients in them never had today's medicines. Ask your haematologist what your own results suggest.

"If it is this aggressive, treatment is pointless."

Many people respond well to modern treatment, at least for a period, and treatment often eases pain, kidney trouble and tiredness. Even when control is not possible, good supportive care makes a real difference.

"We should not tell him how serious it is."

Most patients sense that something is badly wrong. Honest conversations, with the family present, usually make decisions about intensive treatment or transplant easier and fairer to the patient.

"Once the counts look normal, we can stop the tablets."

Normal counts do not mean the disease has gone. Maintenance treatment is planned deliberately. Never stop or change a medicine without your treating team.

Did you know

Every case at CION is discussed at a tumour board before a plan is confirmed. For a rare and fast illness like plasma cell leukaemia, that means your reports are read by more than one specialist, and transplant planning can start early.

Being straight with you

What can this page not tell you?

This page cannot tell you how long anyone will live, or how well treatment will work for your family member. Only a haematologist who knows the reports, the response and the person can begin to answer that, and even then the picture changes as treatment goes on.

Questions worth asking your haematologist

Is this primary or secondary plasma cell leukaemia? What did the FISH test show? Is a stem cell transplant a possibility, and when would it be arranged? How will we know whether treatment is working? What should we do at night if a fever or confusion starts?

Comfort matters at every stage

Palliative care, meaning care focused on comfort and symptoms, is not only for the end of life. Pain from bone damage, tiredness and worry can be treated alongside cancer treatment. Ask for it early.

What CION does, and what it arranges

CION's haematology team reviews the reports, presents the case at a tumour board and plans treatment with you. CION does not perform stem cell transplants. Where a transplant or a specialised test is needed, the team coordinates it with qualified centres and keeps your care joined up.

If you are the adult child managing this, ask for a single contact person on the team. It saves repeated explanations.

Questions we are asked

Common questions about plasma cell leukaemia

Is plasma cell leukaemia the same as multiple myeloma?

They are closely related. Both involve abnormal plasma cells, and they are treated with many of the same medicines. In plasma cell leukaemia, large numbers of the abnormal cells are also in the blood, which usually means a faster-growing illness needing treatment urgently.

How is it diagnosed?

A blood smear and flow cytometry count the plasma cells circulating in the blood. A bone marrow biopsy, FISH gene tests, protein tests of the blood and urine, kidney and calcium tests, and a scan of the bones complete the picture. The definition was updated in recent years, so older reports may use different criteria.

Can plasma cell leukaemia go into remission?

Yes. Remission means the tests no longer find the disease, or find very little of it. Many people reach a remission with modern treatment. It is not a promise that the disease will not return, which is why maintenance treatment and regular tests follow.

Is my father too old for a transplant?

Age alone does not decide it. Fitness, heart, lung and kidney function, and response to the first treatment matter more. Some older people are suitable, and many who are not still receive effective treatment without transplant. Ask the haematologist to explain the reasoning either way.

What symptoms need urgent help?

Fever or shivering, confusion or extreme drowsiness, passing very little urine, severe vomiting, bleeding, or new weakness in the legs. Go to the nearest emergency department the same day or call 108, and say the person has plasma cell leukaemia.

Why are the kidneys checked so often?

The abnormal proteins made by the cancer cells, and a high calcium level, can damage the kidneys. Kidney function affects which medicines are safe. Drinking enough fluid, as advised by your team, and avoiding painkillers that strain the kidneys unless approved, both help.

Should we look for a clinical trial?

It is a reasonable question, because the illness is rare and newer treatments are being studied. Ask your haematologist whether any trial is open and suitable. Trials have strict entry rules, and joining one should not delay treatment that is needed now.

Is treatment covered by schemes or insurance?

Myeloma-type treatment is often covered by Aarogyasri, PM-JAY, CGHS, ECHS, EHS and cashless insurance, but newer medicines and transplants may be only partly covered. Rules change, so share your card details with the helpline and ask the team to check your current cover.

Your Haematologist

Meet CION's haematologist. One specialist for your blood report and your plan.

Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.

Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Sources

National Cancer Institute — Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ) - Patient Version
Leukemia & Lymphoma Society — Myeloma
Cancer Research UK — Myeloma
National Health Mission — National Health Mission

This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.

Keep reading

Rarer Blood CancersThe other uncommon blood cancers in this guide Solitary PlasmacytomaA localised plasma cell cancer, and how it differs POEMS SyndromeAnother rare plasma cell disorder Blood cancer guideAn overview of blood cancers and their tests

Talk to us

Facing a plasma cell leukaemia diagnosis?

Share the reports with us. CION's haematology team will review them, explain what they show and help plan the next steps. One helpline serves every CION centre.

Call 1800 202 8726

Plasma cell leukaemia: understanding the outlook | CION Cancer Clinics

What is the outlook with plasma cell leukaemia?

What the illness is

Why this page gives no survival figures

What does shape the outlook

Does it matter whether it is primary or secondary?

Which factors change your own outlook?

Response to first treatment

Fitness and age

Kidney function

Gene changes in the cells

On the report as

Blood counts and calcium

How is plasma cell leukaemia usually treated?

Urgent first steps

Induction treatment

Stem cell transplant, if suitable

Maintenance

Regular review

What do families often get wrong about the outlook?

What can this page not tell you?

Questions worth asking your haematologist

Comfort matters at every stage

What CION does, and what it arranges

Common questions about plasma cell leukaemia

Is plasma cell leukaemia the same as multiple myeloma?

How is it diagnosed?

Can plasma cell leukaemia go into remission?

Is my father too old for a transplant?

What symptoms need urgent help?

Why are the kidneys checked so often?

Should we look for a clinical trial?

Is treatment covered by schemes or insurance?

Meet CION's haematologist. One specialist for your blood report and your plan.

Dr. Basudev Pokhrel

Sources

Related pages

Facing a plasma cell leukaemia diagnosis?

Our centres in and around Hyderabad

Haematology Topics

This guide: Rarer Blood Cancers

Counts & tests

Leukaemia, MDS & MPN

Myeloma & lymphoma

Transplant & CAR-T

Blood disorders

Care, cost & support